(1)
Andrade, M. de O.; Gutierres, I. G.; Sousa, R. B.; Testa, L.; Ferrari, A.; Souza, Z. S. de; Ferreira, R. D. P.; Bonadio, R. C. Immune-Related Adverse Events Among Patients With Early-Stage Triple-Negative Breast Cancer Treated With Pembrolizumab Plus Chemotherapy: Real-World Data from the Neo-Real GBECAM-0123 Study. MAST 2026, 35.